Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-24 · accession 0001415889-25-008872 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | 2025-03-24 | KYNB | Wettig Thane | CEO, Dir | P - Purchase | $0.35 | +145.0K | 543.3K | +36% | +$50.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-24 | P | A | 145,000 | $0.35 | 543,329 | D | — | — | (F1) Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.34 to $0.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. |